Viacure GmbH
PrivateCompany Overview
Viacure GmbH is a biotechnology company that develops regenerative therapies for the treatment of type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologydrug discoverytherapeutic antibodiestype 2 diabetesbeta cell regenerationbiotech startuppreclinical researchregenerative medicineInceptordrug developmentbiopharmatranslational researchIP licensingdiabetes treatment
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Viacure GmbH Comparables
Compare Viacure GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DiogenX | 80% | |
| RosVivo Therapeutics | 80% | |
| Pharmasaga Co., Ltd. | 79% | |
Viacure GmbH Funding Rounds
Historical fundraising activity
Viacure GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Viacure GmbH's valuation, stock price, and market status.
See something wrong or outdated?